TARS
TARS
US87650L1035
Tarsus Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.42B EUR
2.72B EUR
3.02B EUR
3.48B EUR
Enterprise Value
2.81B EUR
2.59B EUR
2.99B EUR
3.37B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-203.22x
--
--
--
Price to Sales
5.65x
4.49x
5.64x
9.34x
Price to Book
9.13x
7.85x
8.65x
10.15x
EV/Revenue
4.63x
4.27x
5.58x
9.04x
EV/EBITDA
-60.79x
--
--
--
Price to FCF (P/FCF)
50.74x
48.63x
--
--
EV/FCF
41.63x
46.28x
--
--
FCF Yield
1.97%
2.06%
-1.05%
-0.03%
ende